Samuel J. Vidal

1.5k citations
12 papers · 798 indexed · h-index 7
Topics
Cancer Cells and Metastasis (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Tuberculosis Research and Epidemiology (3 papers)
Partner nations
United StatesSpainFrance

In The Last Decade

Samuel J. Vidal

12 papers receiving 793 citations

Peers

Samuel J. Vidal
Comparison fields: 5 of 80
  • Molecular Biology 473
  • Oncology 308
  • Cancer Research 217
  • Pulmonary and Respiratory Medicine 164
  • Immunology 73
Replace Ken Suzawa with:
Ken Suzawa Japan
Ankur Sharma United States
Anatol Oleksijew United States
Chunwei W. Lai United States
Nathalie Dugot‐Senant France
Marianna Scrima Italy
Fábio Pittella Silva Brazil
Irene Vanni Italy
Ainura Kyshtoobayeva United States
Misty D. Bear United States
Samuel J. Vidal relative to Ken Suzawa Japan Ken Suzawa's profile →
Citations per field
00.5×3.6×
Ken Suzawa · 1×
Citations per year

Countries citing papers authored by Samuel J. Vidal

Since Specialization
Citations

This map shows the geographic impact of Samuel J. Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel J. Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel J. Vidal more than expected).

Fields of papers citing papers by Samuel J. Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel J. Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel J. Vidal. The network helps show where Samuel J. Vidal may publish in the future.

Co-authorship network of co-authors of Samuel J. Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel J. Vidal. A scholar is included among the top collaborators of Samuel J. Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel J. Vidal. Samuel J. Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 7
3 7
4 5
5 24
6 32
7 3
8 160
9 5
10 1
11 215
12 338

About Samuel J. Vidal

Samuel J. Vidal is a scholar working on Infectious Diseases, Oncology and Immunology, having authored 12 papers that have together received 798 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Cancer Research (217 citations), Oncology (308 citations) and Hepatology (69 citations). Samuel J. Vidal has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Josep Domingo‐Domenech, Carlos Cordon‐Cardo, Verónica Rodríguez-Bravo, Matt D. Galsky, S. Aidan Quinn, Janis de la Iglesia-Vicente, Dennis M. Bonal, Elizabeth Charytonowicz, José M. Silva and Mireia Castillo-Martín. Their work appears in journals such as Cell, Cancer Cell and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026